Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 792 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Niraparib / Abiraterone Acetate Lisocabtagene Maraleucel Shows Deep, Durable Responses in Patients with Relapsed or Refractory MZL After at Least Two Previous Lines of Systemic Therapy New ESMO Local and Locoregional Prostate Cancer Living Guideline v1.0 MOST POPULAR Androgen Receptor Pathway Inhibitors Outperform Taxanes in Patients with mCRPC with... September 6, 2024 27-Year-Old Diagnosed with Cancer at 20 Weeks Pregnant Gives Birth Amid... July 3, 2020 Pink Van Makes the Rounds Throughout Rural New Zealand to Offer... February 24, 2021 FDA Approves Cemiplimab-rwlc for Advanced Non-Small Cell Lung Cancer With High... February 23, 2021 Load more HOT NEWS Patient Guide in Testicular Cancer Now Available Also in German Impressive Responses to PD-1 Blockade in a Large Cohort of Children... Adding Gemcitabine to Cisplatin Once per Week Concurrently with IMRT Significantly... Women in Science: Celebrating with our Women of Influence initiative
